How have TSOI shares performed in 2024?

Therapeutic Solutions International's stock was trading at $0.0010 at the beginning of the year. Since then, TSOI shares have decreased by 30.0% and is now trading at $0.0007. View the best growth stocks for 2024 here .

Are investors shorting Therapeutic Solutions International?

Therapeutic Solutions International saw a drop in short interest in March. As of March 31st, there was short interest totaling 148,600 shares, a drop of 45.4% from the March 15th total of 272,300 shares. Based on an average daily volume of 39,779,500 shares, the short-interest ratio is currently 0.0 days. View Therapeutic Solutions International's Short Interest .

When is Therapeutic Solutions International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 16th 2024. View our TSOI earnings forecast .

What other stocks do shareholders of Therapeutic Solutions International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Therapeutic Solutions International investors own include Carnival Co. & (CCL) , Korea Electric Power (KEP) , Redwood Trust (RWT) , Signet Jewelers (SIG) , Goldman Sachs Physical Gold ETF (AAAU) , Aurora Cannabis (ACB) , AeroVironment (AVAV) , Booking (BKNG) , Chimera Investment (CIM) and Enterprise Products Partners (EPD) .

How do I buy shares of Therapeutic Solutions International?

Shares of TSOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:TSOI

Therapeutic Solutions International (TSOI) Stock Price, News & Analysis

→ The #1 Opportunity of the decade? (From Behind the Markets) (Ad)

Free TSOI Stock Alerts

$0.0007

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.0007
▼
$0.0008
50-Day Range: N/A
52-Week Range: $0.0006
▼
$0.0063

Volume: 32.69 million shs
Average Volume: 16.22 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings Short Interest

Get Therapeutic Solutions International alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Therapeutic Solutions International Stock (OTCMKTS:TSOI)

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPSA, a blend of NanoStilbene and broccoli sprout extracts; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. In addition, it develops therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology. Therapeutic Solutions International, Inc. was founded in 2007 and is headquartered in Elk City, Idaho.

TSOI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TSOI Stock News Headlines

April 14, 2024 | finance.yahoo.com

Aion Therapeutic Responds to First-Ever U.S. Drinking Water Standard Making PFAS Removal a Top Priority

April 11, 2024 | americanbankingnews.com

Short Interest in Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Drops By 45.4%

April 19, 2024 | Behind the Markets (Ad)

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

April 11, 2024 | americanbankingnews.com

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Short Interest Update

April 8, 2024 | usnews.com

Therapeutic Vaccine Prevents Pancreatic Cancer's Recurrence in 3-Year Trial

April 8, 2024 | finance.yahoo.com

Therapeutic Solutions International, Inc. (TSOI)

April 2, 2024 | finance.yahoo.com

Kelonia Therapeutics to Present Preclinical Data Highlighting Therapeutic Potential of in vivo CAR-T Cell Therapy in Multiple Myeloma

April 2, 2024 | finance.yahoo.com

Therapeutic mRNA Patent Monitoring Service 2024: Track Competitors' IP Activities and their Future Intentions

April 19, 2024 | Behind the Markets (Ad)

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

March 18, 2024 | msn.com

Aveeno Therapeutic Shave Gel with Oat and Vitamin E to Help Prevent Razor Bumps, Now 24% Off

March 11, 2024 | msn.com

Rising Stars Therapeutic Riding Center: Cowgirl Bunco night coming soon

March 11, 2024 | finance.yahoo.com

Arthritic Therapeutic Market to Reach $ 136.1 billion, Globally, by 2032 at 5.5% CAGR: Allied Market Research

March 4, 2024 | finance.yahoo.com

Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients

February 29, 2024 | finance.yahoo.com

Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product

February 26, 2024 | finance.yahoo.com

Therapeutic Solutions International Files Patent on "Facilitating Effects" of JadiCells on Gene Therapy Mediated Cell Differentiation

February 26, 2024 | businesswire.com

Therapeutic Solutions International Files Patent on “Facilitating Effects” of JadiCells on Gene Therapy Mediated Cell Differentiation

February 23, 2024 | benzinga.com

Therapeutic Solns Intl Stock (OTC:TSOI), Analyst Ratings, Price Targets, Predictions

February 20, 2024 | finance.yahoo.com

Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease

February 18, 2024 | msn.com

Patient safety advocate 'horrified' at government's plans to drop Therapeutic Products Act

February 6, 2024 | finance.yahoo.com

Peptide Therapeutics Market Surges Towards USD 101.7 Billion by 2033 | Analyzing Growth in Therapeutic Innovations and Disease Management

February 1, 2024 | msn.com

Cosmetic injectables industry slams crackdown on advertising rules by Therapeutic Goods Administration

January 31, 2024 | finance.yahoo.com

APAC Epilepsy Therapeutic Market Poised for Growth, Set to Expand by USD 449.35 Mn through 2023-2028

January 22, 2024 | finance.yahoo.com

Therapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities

January 3, 2024 | finance.yahoo.com

Therapeutic Solutions International Subsidiary Immunotherapy Company Res Nova Bio, Inc. Announces Positive Data on First Four Advanced Cancer Patients Treated with FloraStilbene™

December 11, 2023 | finance.yahoo.com

Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease

November 27, 2023 | finance.yahoo.com

Therapeutic Solutions International and Campbell Neurosciences Publish on Nutritional Modulation of the Indolamine 2,3 Dioxygenase Pathway as a Non-Toxic Means of Addressing Depression

November 20, 2023 | finance.yahoo.com

Therapeutic Solutions International Collaborates on Peer-Reviewed Publication on Personalized Immunotherapy for Brain Cancer Using mRNA

See More Headlines

Receive TSOI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Therapeutic Solutions International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Next Earnings (Estimated): 5/16/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:TSOI
CUSIP: 883378101
CIK: 1419051
Web: therapeuticsolutionsint.com
Phone: (760) 295-7208
Fax: N/A
Employees: 3
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Timothy George Dixon (Age 66)
Chairman, CEO, President & CFO
Comp: $240k
Dr. Feng Lin M.D. (Age 53)
Ph.D., Chief Scientific Officer
Dr. James Drew Veltmeyer M.D. (Age 58)
Chief Medical Officer, Vice Chairman of CTE Advisory Board & Member of Scientific Advisory Board
Ms. Famela Ramos (Age 47)
Vice President of Business Development
Ms. Serena Robella
Director of Sales

Key Competitors

View All Competitors

TSOI Stock Analysis - Frequently Asked Questions

How have TSOI shares performed in 2024?: Therapeutic Solutions International's stock was trading at $0.0010 at the beginning of the year. Since then, TSOI shares have decreased by 30.0% and is now trading at $0.0007.
View the best growth stocks for 2024 here.
Are investors shorting Therapeutic Solutions International?: Therapeutic Solutions International saw a drop in short interest in March. As of March 31st, there was short interest totaling 148,600 shares, a drop of 45.4% from the March 15th total of 272,300 shares. Based on an average daily volume of 39,779,500 shares, the short-interest ratio is currently 0.0 days.
View Therapeutic Solutions International's Short Interest.
When is Therapeutic Solutions International's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 16th 2024.
View our TSOI earnings forecast.

What other stocks do shareholders of Therapeutic Solutions International own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Therapeutic Solutions International investors own include Carnival Co. & (CCL), Korea Electric Power (KEP), Redwood Trust (RWT), Signet Jewelers (SIG), Goldman Sachs Physical Gold ETF (AAAU), Aurora Cannabis (ACB), AeroVironment (AVAV), Booking (BKNG), Chimera Investment (CIM) and Enterprise Products Partners (EPD).
How do I buy shares of Therapeutic Solutions International?: Shares of TSOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TSOI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial